Rogco LP’s NeoGenomics NEO Stock Holding History

Rogco LP’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$438	Hold	30	–	–	﹤0.01%	223
2026 Q1	$223	Hold	30	–	–	﹤0.01%	204
2025 Q4	$353	Hold	30	–	–	﹤0.01%	204
2025 Q3	$232	Buy	+30	New	+$210	﹤0.01%	192

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Rogco LP's NEO Position: Q2 2026 in Review

Rogco LP held its NeoGenomics (NEO) position steady in Q2 2026 at 30 shares worth $438. The position accounts for ﹤0.01% of the portfolio, ranked #223.

Rogco LP first reported a position in NEO in Q3 2025 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Rogco LP held 30 shares of NeoGenomics worth $438 as of Q2 2026.
Rogco LP left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of Rogco LP's portfolio in Q2 2026, its #223 holding.
Rogco LP first reported a position in NeoGenomics in Q3 2025 and has held it in 4 quarters since.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Rogco LP's 13F filing for Q2 2026, filed 30 Jul 2026.